CTLA4-Ig in activated macrophages induces significant down-regulation in the cellular production of IL-6, TNF-alpha, IL1-beta, and TGF-beta for the treatment of RA [45]. The gene discussed is CTLA4; the disease is rheumatoid arthritis.